{"id":"NCT03739203","sponsor":"AbbVie","briefTitle":"The Objective of This Study is to Evaluate the Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD) Who Have Had an Inadequate Response to Antidepressants Alone","officialTitle":"A Double-Blind, Placebo-Controlled Study of Cariprazine as an Adjunct to Antidepressants in the Treatment of Patients With Major Depressive Disorder Who Have Had an Inadequate Response to Antidepressants Alone","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2018-11-10","primaryCompletion":"2021-09-06","completion":"2021-09-06","firstPosted":"2018-11-13","resultsPosted":"2022-09-21","lastUpdate":"2022-09-21"},"enrollment":752,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Major Depressive Disorder"],"interventions":[{"type":"DRUG","name":"Cariprazine","otherNames":["VRAYLAR®"]},{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"Antidepressant Therapy (ADT)","otherNames":[]}],"arms":[{"label":"Placebo + ADT","type":"PLACEBO_COMPARATOR"},{"label":"Cariprazine 1.5 mg/day + ADT","type":"EXPERIMENTAL"},{"label":"Cariprazine 3 mg/day + ADT","type":"EXPERIMENTAL"}],"summary":"The objective of this study is to evaluate the efficacy, safety and tolerability of cariprazine as an adjunctive treatment to antidepressant therapy (ADT) in patients with MDD who have had an inadequate response to antidepressants alone.","primaryOutcome":{"measure":"Change From Baseline to Week 6 in the MADRS (Montgomery-Åsberg Depression Rating Scale) Total Score","timeFrame":"Baseline and Week 6","effectByArm":[{"arm":"Placebo + ADT","deltaMin":-13.4,"sd":0.7},{"arm":"Cariprazine 1.5 mg/Day + ADT","deltaMin":-13.8,"sd":0.69},{"arm":"Cariprazine 3 mg/Day + ADT","deltaMin":-14.8,"sd":0.7}],"pValues":[{"comp":"OG000 vs OG001","p":"0.6798"},{"comp":"OG000 vs OG002","p":"0.1245"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":10,"exclusionCount":2},"locations":{"siteCount":112,"countries":["United States","Canada","Czechia","Finland","Poland","Puerto Rico","Serbia","Slovakia"]},"refs":{"pmids":["37585254"],"seeAlso":["http://rxabbvie.com"]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":250},"commonTop":["HEADACHE","AKATHISIA","INSOMNIA","NAUSEA","SOMNOLENCE"]}}